Regulatory Education for Industry (REdI) Annual Conference 2024: Innovation in Medical Product Development

Add to iCal Calendar 0

Date/Time
Date(s) - 29 May 2024 until 30 May 2024
5:30 AM - 1:30 PM

Location


 
Regulatory Education for Industry (REdI) Annual Conference 2024:
Innovation in Medical Product Development
Date: May 29 – 30, 2024
Day1:  –  ET
Day2:  –  ET
This FREE FDA program is offered in person and online. 

Location

Hybrid

Attend In Person or Online

Click HERE for Onsite Attendance Information Details

REGISTER


AGENDA Coming Soon | No Cost

Visit CDER Small Business and Industry Assistance Page

DRUGS, DEVICES, AND BIOLOGICS
TRACKS WILL OFFER AN OPPORTUNITY FOR 1:1 QUESTIONS ONSITE

Learn directly from the FDA’s regulatory experts in medical product centers: drugs, devices, and biologics. This course is designed to provide participants with a strong, basic foundation in the FDA’s regulatory requirements, and also create awareness of current activities.

Speakers:

Patrizia Cavazzoni M.D.
Director
Center for Drug Evaluation and Research (CDER)

Jeff Shuren M.D., J.D.
Director
Center for Devices and Radiological Health (CDRH)

Peter Marks M.D., PhD.
Director
Center for Biologics Evaluation and Research (CBER)

PLENARY

Innovation of medical products, whether it be drugs, devices, or biologics, is a continual journey that advances the needs of patients today and of future generations. Innovation takes the form in many spaces such as research, product design, data collection and analysis, and we’re currently bearing witness to a golden age of technology involving artificial intelligence and genomics. This session will provide a perspective of the current state at the FDA, both with current activities and what’s to come.

 

DRUGS TRACK    DEVICES TRACK    BIOLOGICS TRACK

 

CONTINUING EDUCATION

Real-time attendance is required for the certificate of attendance which can be used in support of CEs for the following professional organizations. Certificates are only available during the two weeks post-event.

This course has been pre-approved by:

  • RAPS as eligible for a maximum of 12 credits for a two-day event (appropriate to real-time attendance) towards a participant’s RAC recertification upon full completion.
  • SOCRA who accepts documentation of candidate participation in continuing education programs for re-certification if the program is applicable to clinical research regulations, operations or management, or to the candidate’s clinical research therapeutic area.
  • SQA as eligible for 1 non-GCP or non-GLP unit for every 1 hour of instructional time towards a participant’s RQAP re-registration.
  • ACRP for continuing education in clinical research. ACRP will provide 1 ACRP contact hour for every 45-60 minutes of qualified material.

TECHNICAL INFORMATION